Ambu (AMBU-B.CO) Financial Analysis & Valuation | Quarter Chart

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors;... more
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services wo... more

Company facts

Reported company information and share structure.

Company Share structure
Market Cap$2.81BExchangeCPH
SectorHealthcareIndustryMedical - Devices
CountryDKCEOBritt Meelby Jensen
IPO Date2004-02-11CAGR10.77%
Employees5,000Websitewww.ambu.com
Div. Yield0.84%Payout Ratio23%
Buy Back Yield1.19%Total Yield2.03%
AMBU-B.CO chart loading...

Key metrics

Reported fundamentals and market-derived technical indicators.

Fundamentals Technicals
Enterprise Value$18.14BP/E Ratio38.53
Forward P/E22.92PEG Ratio-1.12
P/S Ratio2.06P/B Ratio2.06
P/CF Ratio15.08P/FCF Ratio20.87
EPS$0.27EPS Growth 1Y28.99%
EPS Growth 3Y—EPS Growth 5Y58.63%
Revenue Growth 1Y4.63%Gross Margin0.56%
Operating Margin0.11%Profit Margin0.08%
ROE0.08%ROA0.06%
ROCE0.1%Current Ratio2.92
Quick Ratio1.73Cash Ratio0.67
Debt/Equity0.09Interest Coverage19.24
Altman Z Score9.72Piotroski Score6

View Ambu financial charts →

Ambu (AMBU-B.CO) valuation & financials

Ambu (AMBU-B.CO) has a market capitalization of 2.81B DKK and trades at a price-to-earnings ratio of 38.5. It operates in the Healthcare sector (Medical - Devices).

Ambu's revenue grew +4.6% over the last year.

Ambu's next earnings report is scheduled for August 26, 2026; analysts estimate EPS of 0.09 DKK.

📈 Analysts estimate AMBU-B.CO EPS of 0.09 DKK for the upcoming quarter. See Ambu revenue & EPS analyst forecasts for the next four quarters with Quarter Chart Premium.

Ambu (AMBU-B.CO) — frequently asked questions

When does Ambu (AMBU-B.CO) report earnings next?

Ambu is expected to report earnings on August 26, 2026. Analysts estimate EPS of 0.09 DKK.

What is Ambu's market cap?

Ambu (AMBU-B.CO) has a market capitalization of 2.81B DKK.

What is AMBU-B.CO's P/E ratio?

Ambu trades at a price-to-earnings ratio of 38.5, with trailing twelve-month EPS of 0.27 DKK.

How fast is Ambu growing?

Ambu's revenue grew +4.6% over the last year.

Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Roche (ROG.SW) · Merck (MRK)

Ambu revenue & earnings charts →